5-136033852-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_000358.3(TGFBI):c.224G>A(p.Gly75Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000358.3 missense
Scores
Clinical Significance
Conservation
Publications
- epithelial-stromal TGFBI dystrophyInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- granular corneal dystrophy type IInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- granular corneal dystrophy type IIInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- lattice corneal dystrophy type IInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Reis-Bucklers corneal dystrophyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- Thiel-Behnke corneal dystrophyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- epithelial basement membrane dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBI | NM_000358.3 | c.224G>A | p.Gly75Asp | missense_variant | Exon 2 of 17 | ENST00000442011.7 | NP_000349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBI | ENST00000442011.7 | c.224G>A | p.Gly75Asp | missense_variant | Exon 2 of 17 | 1 | NM_000358.3 | ENSP00000416330.2 | ||
TGFBI | ENST00000504185.5 | n.292G>A | non_coding_transcript_exon_variant | Exon 2 of 5 | 4 | |||||
TGFBI | ENST00000506699.5 | n.289G>A | non_coding_transcript_exon_variant | Exon 2 of 17 | 2 | |||||
TGFBI | ENST00000507018.5 | n.140G>A | non_coding_transcript_exon_variant | Exon 2 of 17 | 5 | ENSP00000421540.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461242Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726840 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.224G>A (p.G75D) alteration is located in exon 2 (coding exon 2) of the TGFBI gene. This alteration results from a G to A substitution at nucleotide position 224, causing the glycine (G) at amino acid position 75 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at